ArticleThe oncologist2025

A cohort study of circulating biomarkers to predict the efficacy and prognosis of immune combination therapy in non-small-cell lung cancer.

Yanxia Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.